Achieve Life Sciences Insider Trades
NASDAQ: ACHVHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 1 · $175.18K
- Shares bought / sold
- 0 / 20.63K
- Net activity
- Net selling $175,177
Achieve Life Sciences insider activity
Over the last 12 months, Achieve Life Sciences insiders reported 1 transaction on SEC Form 4: 0 open-market purchases and 1 sale. Insiders bought $0 and sold $175,177 worth of stock, for net insider selling of $175,177. The largest seller was Stewart Richard Alistair, with $175,177 in reported sales.
The most recent filing shows Stewart Richard Alistair (Director) selling 20,626 shares at $8.49 on Aug 19, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ACHV's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ACHV insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 19, 2026 | Stewart Richard AlistairDirector | Sale | 20,626 | $175.18K | Form 4 |
| Sep 18, 2025 | Stewart Richard AlistairChief Executive Officer | Sale | 129,501 | $378.14K | Form 4 |
| Sep 18, 2025 | Stewart Richard AlistairChief Executive Officer | Option exercise | 297,500 | — | Form 4 |
| Sep 18, 2025 | Oki Mark KChief Financial Officer | Sale | 50,060 | $146.18K | Form 4 |
| Sep 18, 2025 | Oki Mark KChief Financial Officer | Option exercise | 168,000 | — | Form 4 |
| Sep 4, 2025 | Xinos JaimeChief Commercial Officer | Sale | 20,854 | $57.77K | Form 4 |
| Sep 4, 2025 | Xinos JaimeChief Commercial Officer | Option exercise | 69,000 | — | Form 4 |
| Sep 4, 2025 | JACOBS CINDYPresident & CMO | Sale | 27,629 | $76.53K | Form 4 |
| Sep 4, 2025 | JACOBS CINDYPresident & CMO | Option exercise | 110,000 | — | Form 4 |
| Sep 4, 2025 | KING THOMAS BRAXTONDirector | Sale | 139,858 | $387.41K | Form 4 |
| Sep 4, 2025 | KING THOMAS BRAXTONDirector | Option exercise | 455,000 | — | Form 4 |
| Sep 4, 2025 | Wan JerryPrincipal Accounting Officer | Sale | 14,070 | $38.97K | Form 4 |
| Sep 4, 2025 | Wan JerryPrincipal Accounting Officer | Option exercise | 34,100 | — | Form 4 |
| Mar 17, 2025 | Stewart Richard AlistairChieve Executive Officer | Buy | 10,000 | $28.60K | Form 4 |
| Mar 17, 2025 | Oki Mark KChief Financial Officer | Buy | 10,000 | $28.89K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4